Uruguay
metaBIX Biotech, founded in 2022, is positioning itself as a pivotal player in biotechnology. With its innovative blend of AI and biotech, metaBIX Biotech is carving out a significant niche in predicting diseases caused by viruses and bacteria that impact plants, animals, and humans. Their approach not only aims to boost agribusiness profits but also enhances human safety, aligning with their ambitious slogan: "metaBIX Biotech's AI and biotech blue ocean model boosts agribusiness profits and human safety."
Headquartered in Uruguay, the company recently secured a $1.00M early VC investment on 01 September 2025 from notable investors including AngelHub, Vedanta Capital, The Board, and AIR capital. This injection of capital will likely bolster their research and development efforts, propelling their innovative solutions onto the global stage. For investors, metaBIX Biotech represents a promising opportunity to engage with a cutting-edge company at the forefront of agri-biotechnological advancements.
